| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V15104 | SPD-304 | 869998-49-2 | SPD-304 is a novel, potent and selective inhibitor of tumor necrosis factor α (TNFα) withan IC50 of 22 µM forpreventing binding to the TNF Receptor 1 (TNFR1). |
|
V0038 | QNZ (EVP4593; CAY10470) | 545380-34-5 | QNZ (also known as EVP-4593 or CAY-10470),a quinazoline derivative, is a novel and potentNF-κB inhibitor, which shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM in human Jurkat T cells, respectively. |
|
V10414 | Hypaconitine | 6900-87-4 | Hypaconitine is a highly toxic natural active ingredient extracted from the genus Aconitum and is widely utilized in study/research of rheumatic diseases. |
|
V31112 | Mesaconitine | 2752-64-9 | Mesaconitine is the main active ingredient of Aconitum plants and has a variety of pharmaceutical effects. |
|
V0037 | Necrostatin-1 (Nec-1) | 4311-88-0 | Necrostatin-1 (Nec-1) is a novel, potent and specific RIP1 (receptor-interacting protein 1) kinase inhibitor that inhibits TNF-α-induced necroptosis with EC50 of 490 nM in 293T cells. |
|
V6027 | (S)-Tipifarnib | 192185-71-0 | Tipifarnib S enantiomer is the S-enantiomer of Tipifarnib, which is a highly efficient and specific inhibitor of farnesyltransferase with IC50 of 0.6 nM. |
|
V0036 | Thalidomide (Immunoprin, Contergan and Thalomid) | 50-35-1 | Thalidomide (trade names Immunoprin, Contergan and Thalomid among others) is a potent immunomodulatory agent and a drug approved in the 1950s. |
|
V0035 | Pomalidomide (CC4047 or actimid) | 19171-19-8 | Pomalidomide (formerly also known as CC-4047 or actimid), an analog of thalidomide, is a potent andorally bioavailable immunomodulatory molecule with antineoplastic activity. |